123 related articles for article (PubMed ID: 35114371)
1. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic 1,2,3-Triazoles as Potential Leads Targeting the S100A2-p53 Complex: Synthesis and Cytotoxicity.
Sun J; Baker JR; Russell CC; Cossar PJ; Ngoc Thuy Pham H; Sakoff JA; Scarlett CJ; McCluskey A
ChemMedChem; 2021 Sep; 16(18):2864-2881. PubMed ID: 34047450
[TBL] [Abstract][Full Text] [Related]
3. Targeting the S100A2-p53 Interaction with a Series of 3,5-Bis(trifluoromethyl)benzene Sulfonamides: Synthesis and Cytotoxicity.
Sun J; Ambrus JI; Russell CC; Baker JR; Cossar PJ; Pirinen MJ; Sakoff JA; Scarlett CJ; McCluskey A
ChemMedChem; 2021 Sep; 16(18):2851-2863. PubMed ID: 34047071
[TBL] [Abstract][Full Text] [Related]
4. Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.
Sun J; Baker JR; Russell CC; Pham HNT; Goldsmith CD; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
RSC Med Chem; 2023 Nov; 14(11):2246-2267. PubMed ID: 37974967
[TBL] [Abstract][Full Text] [Related]
5. Pyrimidyn-Based Dynamin Inhibitors as Novel Cytotoxic Agents.
Odell LR; Chau N; Russell CC; Young KA; Gilbert J; Robinson PJ; Sakoff JA; McCluskey A
ChemMedChem; 2022 Jan; 17(1):e202100560. PubMed ID: 34590434
[TBL] [Abstract][Full Text] [Related]
6. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
8. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
9. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
11. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.
Spare LK; Falsetta P; Gilbert J; Harman DG; Baker MA; Li F; McCluskey A; Clegg JK; Sakoff JA; Aldrich-Wright JR; Gordon CP
ChemMedChem; 2017 Jan; 12(2):130-145. PubMed ID: 27921386
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
[TBL] [Abstract][Full Text] [Related]
15. Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer.
Hopkins MD; Costello IJ; Brandeburg ZC; Slay EL; Zanders LA; Dunn CE; Derewonko CA; Davitt CL; Reeder MA; Prichard K; Chiew B; McCluskey A; Sheaff RJ; Lamar AA
ChemMedChem; 2023 Oct; 18(19):e202300265. PubMed ID: 37421174
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
17. A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.
Lin AJ; Russell CC; Baker JR; Frailey SL; Sakoff JA; McCluskey A
Org Biomol Chem; 2016 Sep; 14(37):8732-8742. PubMed ID: 27714138
[TBL] [Abstract][Full Text] [Related]
18. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
